/
At Mirion, we deliver vital protection that unlocks the transformative potential of radiation to move science, industry and medicine forward. For more than 60 years Mirion and our predecessor companies have provided products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality…
Operating margin is thin at 5.57%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 7.5%, steady but not accelerating.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$981M
▲ +7.5% YoY
Net Income (TTM)
$25M
▲ +179.8% YoY
Op. Margin
4.74%
▲ +2.7pp YoY
ROIC
2.04%
▲ +1.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$89M
▲ +112.5% YoY
Op. Cash Flow (TTM)
$127M
▲ +44.6% YoY
Net Debt
$80M
Cash & Equiv.
$398M
5Y CAGR: +14.1%
5Y CAGR: +40.4%
Continue Research